Convidados Internacionais Confirmados

Adrian V. Hernandez MD, PhD is currently Associate Professor of Comparative Effectiveness and Outcomes Research at the Health Outcomes, Policy and Evidence Synthesis (HOPES) Group of the University of Connecticut School of Pharmacy, Storrs, CT, USA. He is also Member of the University of Connecticut/Hartford Hospital Evidence-based Practice Center, Hartford, CT, USA, and Researcher of the Vicerrectorado de Investigación, Universidad San Ignacio de Loyola (USIL), Lima, Peru.
Professor Hernandez received his MD degree from the Universidad Nacional Mayor de San Marcos School of Medicine, Lima, Peru, and MSc and PhD degrees in Clinical Epidemiology at Erasmus University Rotterdam, the Netherlands. He has previously worked as Researcher at Erasmus University Medical Center Rotterdam, the Netherlands, and as Assistant Professor of Medicine at the Cleveland Clinic Lerner School of Medicine of Case Western Reserve University, Clevelamd, OH, USA.
Professor Hernandez has expertise in prognostic modeling, systematic reviews and meta-analyses, health technology assessments, and clinical practice guidelines in a range of medical fields, including infectious diseases and HIV-associated infections. He holds editorships and reviewer positions in several peer-reviewed journals. As of today, Prof. Hernandez has 184 peer-reviewed publications in Pubmed (


Dr. Eva Harris is a Professor in the Division of Infectious Diseases and Vaccinology in the School of Public Health, Director of the Center for Global Public Health, and Chair of the Infectious Diseases and Immunity Graduate Group at the University of California, Berkeley. She has developed multidisciplinary approaches to study the virology, pathogenesis, immunology, epidemiology, clinical aspects, and control of dengue, Zika, and chikungunya, the most prevalent mosquito-borne viral diseases in humans. Her work addresses viral and host factors that modulate disease severity and investigates immune correlates of protection and pathogenesis using in vitro approaches, animal models, and research involving human populations. This has been achieved through her research program at UC Berkeley and in endemic Latin American countries, particularly Nicaragua, where she has worked extensively for over 30 years. In 1997, she received a MacArthur Award for work over the previous ten years developing programs to build scientific capacity in developing countries to address public health and infectious disease issues. She is also the co-founder and President of the Sustainable Sciences Institute, which works to improve public health in developing countries by building local capacity for scientific research on priority diseases. She has published over 280 peer-reviewed articles, as well as a book on her international scientific work, and has received numerous awards and for her scientific and global health achievements.


Hajo Grundmann, born in 1955, studied Sinology, Nursing and Human Medicine at the Universities of Bochum and Freiburg, Germany. He specialised in Clinical Tropical Medicine, Medical Microbiology and Hygiene & Environmental Medicine and received his PhD at the University of Freiburg, Germany and an MSc in Epidemiology of Communicable Diseases at the London School of Hygiene. He worked clinically as a medical doctor at university hospitals in Freiburg, Berlin, and Nottingham and carried out extensive field studies in Taiwan, Venezuela and Tanzania. For eight years, he was leading the European Antimicrobial Resistance Surveillance System (EARSS) funded by the European Commission and the Dutch Ministry of Health as the Head of Department for Microbiology at the Dutch National Institute for Public Health and the Environment (RIVM). Currently, he is the Director of the Institute for Infection Prevention and Hospital Epidemiology at the Medical Centre – University of Freiburg, Germany. He also holds the Chair for Infectious Diseases Epidemiology at the University of Groningen. His major research interests are the molecular evolution, epidemiology, population dynamics and health impact of emerging antimicrobial resistance and health care associated infections. – Address: University Medical Centre Freiburg, Faculty of Medicine, University of Freiburg, Breisacherstr. 115b, 79106 Freiburg, Germany.


Universidad Complutense de Madrid and Hospital Universitario 12 de Octubre, Madrid, Spain.
José María Aguado is Professor of Medicine at the Universidad Complutense de Madrid, Spain, and Head of the Infectious Diseases Unit of the Hospital Universitario 12 de Octubre, Madrid, Spain.
Professor Aguado completed his medical training at the Institute of Transplantation, University of Pittsburgh, Pennsylvania, USA.
He is a past-Chairman of the Study Group of Infection in Compromised Patients (ESGICH) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
Professor Aguado is also the Coordinator of the Program of Infections in Transplant and other Immunocompromised Patients of the Spanish Network of Infectious Diseases (REIPI).
He has recently been appointed as Member of the Executive Council of the International Immunocompromised Host Society (ICHS).
Professor Aguado has published over 370 articles in international journals, most of which are related to infection in the immunocompromised patient.


Professor Schwaber is the director of the National Center for Infection Control of the Israel Ministry of Health in Tel Aviv. A native of Boston, USA, he pursued his medical studies at the Albert Einstein College of Medicine in New York, medical residency at Massachusetts General Hospital in Boston and Hadassah University Hospital in Jerusalem, Israel, and training in infectious diseases and epidemiology at Beth Israel Deaconess Medical Center and the Harvard School of Public Health, in Boston.
In addition to his duties with the Ministry of Health, he practices internal and infectious diseases medicine at Tel Aviv Sourasky Medical Center and Maccabi Healthcare Services, is Associate Professor of Medicine at the Sackler Faculty of Medicine at Tel Aviv University, and is a reserve officer in the Medical Corps of the Israel Defense Forces. His primary research interest is the epidemiology of antimicrobial resistance in healthcare-associated bacteria.
He lives in Modiin, Israel, with his wife and three daughters.


Pedro Cahn has been working in infectious diseases for the last 45 years and has been involved in the HIV/AIDS arena since 1982. He has served as Chief of Infectious Diseases at the Juan Fernandez Hospital, where he is now Senior Consultant. He is President of Fundación Huésped in Buenos Aires, the largest NGO in Argentina serving patients with and at risk of HIV/AIDS. Dr. Cahn is Professor of Infectious Diseases at the Buenos Aires University Medical School. He is also a Past-President of the International AIDS Society. He is also an external advisor for UNAIDS, theWorld Health Organization (WHO), the Pan-American Health Organization, UNITAID, Doctors without Borders, as well as a member of the antiretroviral guidelines panel both for WHO and a former member of the guidelines panel of the International Antiviral Society-USA. Dr. Cahn has published more than 190 peer-reviewed papers and book chapters.